H. Lundbeck A/S

The company is active in endocrine disease research, including Cushing's disease and congenital adrenal hyperplasia. These programmes reflect a therapeutic interest in conditions involving abnormal hormone regulation and adrenal function.

• Cushing's disease
• Congenital adrenal hyperplasia

Its work in this area also connects with broader investigation of disorders linked to cortisol imbalance.

H. Lundbeck A/S is involved in research on thyroid eye disease, including moderate-to-severe TED and associated proptosis. This places a clear emphasis on inflammatory eye disease and its impact on orbital symptoms.

• Thyroid eye disease
• Moderate-to-severe TED
• Proptosis

The sponsor’s activity in this field highlights interest in conditions affecting vision, eye appearance, and ocular discomfort.

The sponsor also supports research in neurology and sleep medicine, with studies in multiple system atrophy, Parkinson's disease, and narcolepsy. These programmes reflect attention to progressive neurodegenerative disease and disorders of wakefulness.

• Multiple system atrophy
• Parkinson's disease
• Narcolepsy

Its research in this area covers both movement-related neurological conditions and central disorders of sleep regulation.

H. Lundbeck A/S includes pain research within its clinical portfolio, indicating interest in symptom relief and sensory symptom control across neurological and headache-related conditions.

• Pain

This area complements its broader work in headache medicine and other disorders with significant symptom burden.